- 全部删除
您的购物车当前为空
Thiethylperazine (Tietilperazina) 是一种可口服且具有高效性的 D2 受体和 H1 受体拮抗剂, 也是一种选择性的ABCC1激活剂,具有抗菌和止吐活性,可减少小鼠中的淀粉样 β (Aβ) 负荷, 用于缓解眩晕,可用于研究阿尔茨海默症和帕金森等神经系统疾病。

Thiethylperazine (Tietilperazina) 是一种可口服且具有高效性的 D2 受体和 H1 受体拮抗剂, 也是一种选择性的ABCC1激活剂,具有抗菌和止吐活性,可减少小鼠中的淀粉样 β (Aβ) 负荷, 用于缓解眩晕,可用于研究阿尔茨海默症和帕金森等神经系统疾病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 347 | In stock | |
| 2 mg | ¥ 490 | In stock | |
| 5 mg | ¥ 828 | In stock | |
| 10 mg | ¥ 1,230 | In stock | |
| 25 mg | ¥ 2,160 | In stock | |
| 50 mg | ¥ 3,220 | In stock | |
| 100 mg | ¥ 4,720 | In stock | |
| 200 mg | ¥ 6,650 | In stock |
Thiethylperazine 相关产品
| 产品描述 | Thiethylperazine (Tietilperazina) is an orally available, highly potent D2 receptor and H1 receptor antagonist and selective ABCC1 activator with antimicrobial and antiemetic activity that reduces amyloid β (Aβ) load in mice, is used to relieve vertigo, and can be used in studies of neurological diseases such as Alzheimer's disease and Parkinson's disease. Alzheimer's and Parkinson's diseases. |
| 体外活性 | Thiethylperazine 以低至 2 μg/mL的浓度增强抗生素万古霉素的活性,并以 MIC 值分别为 8 μg/mL、16 μg/mL和 8 μg/mL抑制万古霉素敏感及耐药的肠球菌株[3]。 |
| 体内活性 | 在年轻的β-淀粉样蛋白前体蛋白(APPswe)和突变型早老素-1(PS1)(APP/PS1)双转基因小鼠中, Thiethylperazine(3 mg/kg;通过肌肉注射;每日两次;持续 30 天)能够显著降低APP/PS1 小鼠体内的 Aβ42 水平[2]。 |
| 别名 | 乙巯匹拉嗪, Tietilperazina |
| 分子量 | 399.62 |
| 分子式 | C22H29N3S2 |
| CAS No. | 1420-55-9 |
| Smiles | CCSc1ccc2Sc3ccccc3N(CCCN3CCN(C)CC3)c2c1 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 80 mg/mL (200.19 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容